MEDGF

Medacta Group S.A.

Healthcare · $3.0B market cap

Verdict

We can't put a fair value on MEDGF right now.

Business quality

4 of 5 clear the 10% bar. What are the Big Five?

Earnings per share growth18.4% a year✓
Equity per share growth20.3% a year✓
Sales growth13.4% a year✓
Free cash flow growth-6.1% a year✗
Return on invested capital10.9%✓

Follow MEDGF

Track it on your watchlist and see the full analysis. Free.

Create a free account

About Medacta Group S.A.

Medacta Group SA is a global developer, manufacturer, and distributor of specialized orthopedic and neurosurgical medical devices. Its operations span Europe, North America, Asia-Pacific, and other international markets. The firm provides advanced solutions, such as personalized kinematic models and cutting-edge 3D planning tools, designed to support a wide array of surgical procedures, including those for the hip…

Medical - Specialties

Fair value and Payback Price are estimates from the company's reported financials, not investment advice. How the Payback Price works

MEDGF stock (Medacta Group S.A.): ownership and insider trades — PaybackPrice